Longyun S. Peng
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability.
Journal: Journal of the American Heart Association
Published: January 31, 2024
Plasma Fibronectin as a Novel Predictor of Coronary Heart Disease: A Retrospective Study.
Journal: Journal of cardiovascular development and disease
Published: August 13, 2023
The Interaction of Dietary Patterns and Genetic Variants on the Risk of Cardiovascular Diseases in Chinese Patients with Type 2 Diabetes.
Journal: Molecular nutrition & food research
Published: May 23, 2023
RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome.
Journal: Molecular genetics & genomic medicine
Published: February 15, 2023
Phosphorylation of CaMK and CREB-Mediated Cardiac Aldosterone Synthesis Induced by Arginine Vasopressin in Rats with Myocardial Infarction.
Journal: International journal of molecular sciences
Published: November 01, 2022
Association of metabolically healthy obesity in young adulthood with myocardial structure and function.
Journal: International journal of obesity (2005)
Published: September 23, 2022
Establishment and consistency verification of the standard operation procedure for laboratory detection of immunoglobulin G oligoclonal bands in cerebrospinal fluid
Journal: Zhonghua yi xue za zhi
Published: August 17, 2021
Salvianolic Acid B Suppresses ER Stress-Induced NLRP3 Inflammasome and Pyroptosis via the AMPK/FoxO4 and Syndecan-4/Rac1 Signaling Pathways in Human Endothelial Progenitor Cells.
Journal: Oxidative medicine and cellular longevity
Published: July 25, 2021
The role of angiopoietin-like protein 4 in phenylephrine-induced cardiomyocyte hypertrophy.
Journal: Bioscience reports
Published: October 11, 2017
Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
Journal: Cardiovascular therapeutics
Published: January 01, 2017
Last Updated: 09/26/2026